Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3302501
Title:
ASSOCIATION D'UN ANTAGONISTE DU PD-1 ET D'UN OLIGONUCLÉOTIDE CPG DU TYPE C POUR LE TRAITEMENT DU CANCER
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
168040541
WO application number:
US2016034275
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3302501
WO publication number:
WO2016196173
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
26/05/2016
Grant date:
22/09/2021
EP publication date:
11/04/2018
WO publication date:
08/12/2016
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
22/09/2021
EP B1 publication date:
22/09/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/05/2022
Expiration date (if granted and all annual fees paid):
26/05/2036
Applicant
1
Name:
Merck Sharp & Dohme Corp.
Legal Form:
From:
22/09/2021
Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)
To:
2
Name:
Surefire Medical, Inc.
Legal Form:
From:
22/09/2021
Address:
d/b/a TriSalus Life Sciences
6272 West 91st Avenue, Westminster, CO 80031, United States (US)
To:
Inventor
1
Name:
YU, Ying
Legal Form:
Address:
Palo Alto, California 94304, United States (US)
2
Name:
DENKER, Andrew Evan
Legal Form:
Address:
Ardmore, PA 19003, United States (US)
3
Name:
SADEKOVA, Svetlana
Legal Form:
Address:
Palo Alto, California 94304, United States (US)
4
Name:
PHAN, Uyen Truong
Legal Form:
Address:
Palo Alto, California 94304, United States (US)
5
Name:
KASTELEIN, Robert A.
Legal Form:
Address:
Palo Alto, California 94304, United States (US)
6
Name:
KAUFMAN, David Ross
Legal Form:
Address:
North Wales, Pennsylvania 19454, United States (US)
7
Name:
COFFMAN, Robert L.
Legal Form:
Address:
Berkeley, California 94710-2753, United States (US)
8
Name:
GUIDUCCI, Cristiana
Legal Form:
Address:
Berkeley, California 94710-2753, United States (US)
9
Name:
JANSSEN, Robert S.
Legal Form:
Address:
Berkeley, California 94710-2753, United States (US)